Sumitomo Dainippon Pharma News and Activities

Presence

Sumitomo Dainippon Pharma develops and sells prescription medicines and healthcare products. Its main offerings include treatments for mental health, oncology, and other diseases for hospitals, clinics, pharmacists, and patients worldwide.

Sumitomo Dainippon Pharma products and services overview:

  • Prescription medicines
  • Mental health therapies
  • Oncology treatments
  • Diabetes care
  • Rare disease drugs
  • Healthcare products

Revenue: ~$2 billion

Employees: 6,800

Headquarters: Osaka, Japan

Sumitomo Dainippon Pharma is owned by Sumitomo Chemical.


Sumitomo Chemical is one of the...

Sumitomo Chemical is a company listed under the stock ticker 4005 (JP).

Sumitomo Chemical has a direct presence in 6 countries.

Sumitomo Chemical has 20 subsidiaries including Aetion, Aramis Biosciences and Asahi Chemical.

They are in:

Executives

View the org chart displaying its 237 main executives

Most searched biographies at Sumitomo Dainippon Pharma

Create your alert
to follow the executive moves at Sumitomo Dainippon Pharma.

Pharmaceuticals

Sumitomo Chemical has 1,912 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals
Popular contacts in Pharmaceuticals

Learn more about the Pharmaceuticals industry

News

Press releases by Sumitomo Dainippon Pharma
Social media about Sumitomo Dainippon Pharma

Get in Touch

Call Sumitomo Dainippon Pharma at +81 66...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board